Dr. Galia Temtsin Krayz is the Director of product Development. Dr. Temtsin Krayz has been involved in the Life Science and Pharma industries since early 2000 and she is one of well recognized and leading experts in these fields. She is an inventor of different proprietary technologies such as SolumerTM-oral; Omexa -transmucosal sublingual and Nasax – intranasal. Dr. Temtsin Krayz most recently held the position of CEO at Solubest Ltd., where she had worked for 15 years and had various positions of increasing responsibility from researcher to CEO. Prior to Solubest, she served at Perrigo (Chemagis, Israel), as a project manager. Dr. Temtsin Krayz has both academic and industrial experience in organic synthesis, process development of APIs and different drug delivery systems.

Dr. Temtsin Krayz holds a B.A. in chemical education with top honors from Moscow Teachers Institute, Russia. M.Sc.in Chemistry from Ben-Gurion University of the Negev, Beer-Sheva, Israel Ph.D. in chemistry with specialization in organic chemistry and nanomaterials from Ben-Gurion University of the Negev, Beer-Sheva, Israel. MBA in BioMed from The College of Management, Academic Studies, Rishon Le Zion, Israel.